EUVIMEDEUVIMED entdecken
Editorial

Beyond the panel: molecular detection is not diagnosis

Vincent Fihman iD, Hervé Jacquier iD, Keyvan Razazi, Nicolas de Prost iD, Paul-Louis Woerther iD

Journal of Antimicrobial Chemotherapy · 2026

DOI: 10.1093/jac/dkag340 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2026. Verfasst von Vincent Fihman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Bacteriology Unit, Department of Infectious Disease Prevention, Diagnosis and Treatment, HU Henri Mondor, AP-HP, Créteil, France. Hauptthemen laut MEDLINE: Bacterial Infections, Molecular Diagnostic Techniques. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the past decade, molecular diagnostics have become widespread in clinical microbiology, a trend accelerated by the COVID-19 pandemic. Syndromic multiplex PCR panels are increasingly incorporated into routine practice and clinical guidelines, owing to their speed and ease of use. However, their expanding success may overshadow some fundamental principles in bacteriology. In this viewpoint, we argue that the decision to start, continue or stop antibiotics must remain basically clinical; that the detection of nucleic acids is not equivalent to the diagnosis of an infection; and that sample quality, colonization, contamination, off-panel pathogens and prior antibiotic exposure may mitigate the interpretation of molecular results. Available trials show that rapid molecular diagnostics can improve antimicrobial prescribing but their impact on clinical outcomes appears conditional on integration with stewardship programmes. Molecular diagnostics should accelerate and refine clinical reasoning, rather than stand for the key element in the decision to treat bacterial infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bacterial InfectionsMolecular Diagnostic TechniquesHumansAnti-Bacterial AgentsAntimicrobial StewardshipCOVID-19Multiplex Polymerase Chain ReactionSARS-CoV-2

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Bacteriology Unit, Department of Infectious Disease Prevention, Diagnosis and Treatment, HU Henri Mondor, AP-HP, Créteil, France.
  • Research Team 'Viruses, Hepatology, Cancer', Institut Mondor de Recherche Biomédicale (INSERM U955), Université Paris-Est Créteil, Créteil, France.
  • Intensive Care Unit, Department of Medicine, HU Henri Mondor, AP-HP, Créteil, France.

ORCID-Profile: Vincent Fihman, Hervé Jacquier, Nicolas de Prost, Paul-Louis Woerther

Zitieren

APA

Fihman, V., Jacquier, H., Razazi, K., de Prost, N., & Woerther, P. L. (2026). Beyond the panel: molecular detection is not diagnosis. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkag340

Vancouver

Fihman V, Jacquier H, Razazi K, de Prost N, Woerther PL. Beyond the panel: molecular detection is not diagnosis. Journal of Antimicrobial Chemotherapy. 2026. doi:10.1093/jac/dkag340

BibTeX
@article{Fihman2026,
  author = {Fihman, Vincent and Jacquier, Hervé and Razazi, Keyvan and de Prost, Nicolas and Woerther, Paul-Louis},
  title = {Beyond the panel: molecular detection is not diagnosis},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  doi = {10.1093/jac/dkag340}
}
Kostenlos starten →